Funding for this research was provided by:
Text and Data Mining valid from 2018-04-10
Received: 22 November 2017
Accepted: 29 March 2018
First Online: 10 April 2018
Ethics approval and consent to participate
: This study was approved by the hospital ethics committee (Ospedale Luigi Sacco, Milan, Italy), with protocol number 110/2013/80/2012/AP, and was conducted according to the Declaration of Helsinki Principle. All patients provided their written informed consent before enrollment.
: Not applicable.
: T. Caballero received speaker fees, consultancy fees, funding for travel and meeting attendance, funding for editorial services and statistical analysis and/or participated in clinical trials/registries from BioCryst, CSL-Behring, GSK, MSD, Novartis, Shire, Sobi.A. Zanichelli received speaker/consultancy fees and/or was a member of medical/advisory boards for CSL Behring, Shire, and SOBI.The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.